We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Gastric Bypass Can Improve Type 2 Diabetes

By HospiMedica staff writers
Posted on 15 May 2003
A study has found that 97% of patients with type 2 diabetes who underwent gastric bypass surgery for obesity had resolution or improvement of their diabetes. More...
The results were presented at the annual meeting of the American Surgical Association in Washington, DC (USA).

The surgery, known as laparoscopic gastric bypass (LGBP), was performed on 1,150 patients over a five-year period. Of these, 240 patients had type 2 diabetes and 192 of them were available for follow-up. Patients lose weight after LGBP because of a decrease in caloric intake resulting from the reduced reservoir capacity of the small stomach.

In the study, diabetes resolved after an average of 62 days following surgery. In patients who had diabetes for less than five years, the disease resolved in 46 days. In patients who had diabetes for more than 10 years, the disease resolved in 98 days. No patients had progression of their diabetes to a more severe form after surgery.

"Patients with the shortest duration and mildest form of diabetes prior to surgery had quicker resolution and significantly better outcomes, suggesting that early surgical intervention is warranted to increase the likelihood of patients having a normal level of glucose in the blood,” said Dr. Philip Schauer, assistant professor of medicine at the University of Pittsburgh School of Medicine (PA, USA), who led the study.





Related Links:
Univ. of Pittsburgh

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Radiation Safety Barrier
RayShield Intensi-Barrier
Pressure Guidewire
SavvyWire
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.